|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Loxo_Oncology
gptkb:Avid_Radiopharmaceuticals
ImClone Systems
|
|
gptkbp:CEO
|
gptkb:David_A._Ricks
|
|
gptkbp:clinicalTrials
|
conducts thousands annually
|
|
gptkbp:employees
|
over 35,000
|
|
gptkbp:founded
|
1876
|
|
gptkbp:founder
|
gptkb:Eli_Lilly
|
|
gptkbp:global_presence
|
over 120 countries
|
|
gptkbp:headquarters
|
gptkb:Indianapolis,_Indiana
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Eli Lilly and Company
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:notableFeature
|
Cymbalta
Humalog
Zyprexa
Trulicity
Emgality
Olumiant
Taltz
Verzenio
Alimta
|
|
gptkbp:partnerships
|
gptkb:Incyte_Corporation
gptkb:Boehringer_Ingelheim
gptkb:Pfizer
|
|
gptkbp:philanthropy
|
gptkb:Lilly_Foundation
|
|
gptkbp:products
|
insulin
antidepressants
oncology drugs
|
|
gptkbp:research
|
Daniel Skovronsky
|
|
gptkbp:research_focus
|
diabetes
cancer
neuroscience
immunology
|
|
gptkbp:revenue
|
$28.5 billion (2020)
|
|
gptkbp:stockExchange
|
gptkb:LLY
|
|
gptkbp:subsidiary
|
gptkb:Elanco_Animal_Health
|
|
gptkbp:sustainability_initiatives
|
community engagement
diversity and inclusion
ethical sourcing
water conservation efforts
carbon footprint reduction
supply chain sustainability
waste reduction strategies
clinical trial transparency
environmental responsibility
employee well-being programs
patient access programs
|
|
gptkbp:website
|
www.lilly.com
|